Developing an Intervention to Optimize Virtual Care Adoption for COPD Management

NCT05986214 | Not Yet Recruiting

• 2 other identifiers: CDX 23-001CDA 21-187
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 2

Brief Summary

VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions like chronic obstructive pulmonary disease (COPD). However, adoption of many VC services has been slow. Lack of awareness about these services is one of the most prominent patient- and healthcare team-facing barriers to adopting VC. This study will develop, refine, and pilot a stakeholder-informed multicomponent implementation strategy to support adoption of VC, referred to as VC-OPTIONS (Virtual Care for Chronic Obstructive Pulmonary Disease Adoption Support). This feasibility trial will pilot the VC-OPTIONS implementation strategy to assess feasibility and acceptability and gather preliminary effectiveness data to inform a larger hybrid effectiveness-implementation trial. The core component of VC-OPTIONS will be the provision of information via VA's Annie texting program to empower patients with knowledge about the array of VC services and how they can be used to support COPD management. It is hypothesized that this strategy will be acceptable and feasible. This work will improve patient and team awareness of and communication about VC services, and support patient access to VC services for COPD management.

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Pulmonary Disease, Chronic Obstructive; Telemedicine; Text Messaging; Implementation Science; Community-Based Participatory Research

Outcome Measures

Primary Outcomes (1)

• Feasibility

  The feasibility of the core implementation component will be assessed with the Feasibility of Intervention Measure (FIM). This is a publicly available, psychometrically sound scale designed to be used in pilot studies as an indicator of implementation success. Participants will be asked to indicate the extent to which they agree with the following statements on a scale from 1 (completely disagree) to 5 (completely agree): I can see other Veterans receiving these messages; I was able to respond to the text messages; texting with Annie was easy; the amount of messages I received from Annie was just right.

  12 Weeks

Secondary Outcomes (6)

• Acceptability

  12 Weeks

• Appropriateness

  12 Weeks

• Awareness of Virtual Care

  12 Weeks

• Intention to Adopt Virtual Care

  Baseline and 12 weeks

• Intent to Communicate about Virtual Care

  Baseline and 12 weeks

Study Arms (1)

VC-OPTIONS

EXPERIMENTAL

Participants will be enrolled in the Annie texting VC-OPTIONS protocol

Other: VC-OPTIONS

Interventions

VC-OPTIONS OTHER

Participants will be enrolled in the Annie texting VC-OPTIONS protocol

Also known as: Texting Intervention

VC-OPTIONS

Eligibility Criteria

• Age: 40 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• VHA user
• US Veteran
• COPD diagnosis
• the ability to speak and understand English
• own a text-enabled phone

You may not qualify if:

• Prior participation in preparatory research for the development of the intervention

Sponsors & Collaborators

• VA Office of Research and Development: lead

Study Sites (2)

VA Bedford HealthCare System, Bedford, MA

Bedford, Massachusetts, 01730-1114, United States

Location

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Boston, Massachusetts, 02130-4817, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Stephanie Robinson, PhD

  VA Bedford HealthCare System, Bedford, MA

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephanie Robinson, PhD

CONTACT

(781) 687-4766; stephanie.robinson5@va.gov

Saige M Calkins, MA BA

CONTACT

(781) 687-4414; saige.calkins@va.gov

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: FED
• Responsible Party: SPONSOR

Model Details: All patient participants will all be assigned to the VC-OPTIONS implementation strategy

Study Record Dates

• First Submitted: July 31, 2023
• First Posted: August 14, 2023
• Study Start (Estimated): September 1, 2026
• Primary Completion (Estimated): August 31, 2027
• Study Completion (Estimated): August 31, 2028
• Last Updated: March 16, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (2)